S. 717: Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025
This bill, titled the Increasing Access to Quality Cardiac Rehabilitation Care Act of 2025, aims to improve access to cardiac and pulmonary rehabilitation programs through changes to the Medicare program. Here are the main highlights of what the bill would do:
1. Changes to Cardiac Rehabilitation Programs
The bill proposes modifications to the current regulations governing cardiac rehabilitation services under Medicare, specifically:
- **Update Professionals Authorized to Prescribe**: It expands the definition of who can prescribe rehabilitation exercises to include not only physicians but also physician assistants, nurse practitioners, and clinical nurse specialists.
- **Broaden Location of Services**: The language specifies that these rehabilitation programs can be provided in a more flexible range of settings, beyond just a physician's office.
2. Changes to Pulmonary Rehabilitation Programs
Similar amendments would be made to pulmonary rehabilitation services under Medicare. Key changes include:
- **Expanding Prescriber Roles**: Just like in the cardiac section, the bill allows for exercise prescriptions by physician assistants, nurse practitioners, and clinical nurse specialists.
- **Flexible Service Locations**: The language for pulmonary rehabilitation will also reflect a broader scope of practice regarding where services are provided.
3. Effective Date of Changes
The amendments made by this bill would become effective 6 months following its enactment, meaning that the updated services and provisions would be available to beneficiaries shortly thereafter.
4. Objective of the Bill
The overarching goal of the bill is to enhance access to quality rehabilitation care for individuals recovering from cardiac or pulmonary conditions, with the intention of improving patient outcomes and supporting healthcare providers in delivering comprehensive care.
Relevant Companies
- MDT (Medtronic): A company that provides medical technology and services, including devices for cardiac rehabilitation. Increased access to rehabilitation programs could lead to greater demand for their products.
- ABT (Abbott Laboratories): They manufacture cardiac monitoring devices. Enhanced rehabilitation programs may result in increased use of their monitoring products.
- ZBH (Zimmer Biomet): A company focused on musculoskeletal healthcare, including rehabilitation and recovery solutions which could be leveraged in expanded rehab programs.
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
2 bill sponsors
Actions
2 actions
| Date | Action |
|---|---|
| Feb. 25, 2025 | Introduced in Senate |
| Feb. 25, 2025 | Read twice and referred to the Committee on Finance. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.
